Home › Funds › SUSQUEHANNA ADVISORS GROUP, INC. › ADPT
SUSQUEHANNA ADVISORS GROUP, INC. position in ADPT
ADAPTIVE BIOTECHNOLOGIES COR · Health Care
SUSQUEHANNA ADVISORS GROUP, INC. reported holding 184,200 shares of ADPT (ADAPTIVE BIOTECHNOLOGIES COR) in its Q2 2026 13F filing — a position valued at US$4.0M, representing 0.10% of its reported portfolio and ranking #48 among its reported holdings. SUSQUEHANNA ADVISORS GROUP, INC. first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How SUSQUEHANNA ADVISORS GROUP, INC.'s ADPT position evolved
SUSQUEHANNA ADVISORS GROUP, INC. first disclosed a stake in ADPT in Q2 2026 at 184,200 shares (US$4.0M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 184.20K | $3.95M | New |
About ADPT and 13F data
ADPT (ADAPTIVE BIOTECHNOLOGIES COR) is a Health Care company. 53 other funds we track also report a position in ADPT — the largest reported positions include Viking Global Investors (US$643.4M), VIKING GLOBAL INVESTORS LP (US$643.4M), Aristotle Atlantic Partners, LLC (US$39.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ADPT
- Viking Global Investors 29.99M sh · $643.37M · Q2 2026
- VIKING GLOBAL INVESTORS LP 29.99M sh · $643.37M · Q2 2026
- Aristotle Atlantic Partners, LLC 1.84M sh · $39.44M · Q2 2026
- PERCEPTIVE ADVISORS LLC 1.22M sh · $26.11M · Q2 2026
- Blue Water Life Science Advisors, LP 1.01M sh · $21.67M · Q2 2026
- Granite Investment Partners, LLC 757.22K sh · $16.24M · Q2 2026
More on SUSQUEHANNA ADVISORS GROUP, INC.
FAQ
How long has SUSQUEHANNA ADVISORS GROUP, INC. held ADPT?
SUSQUEHANNA ADVISORS GROUP, INC. has disclosed ADPT holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is SUSQUEHANNA ADVISORS GROUP, INC.'s current position in ADPT?
As of Q2 2026, SUSQUEHANNA ADVISORS GROUP, INC. holds 184.20K shares of ADPT (ADAPTIVE BIOTECHNOLOGIES COR), valued at $3.95M, representing 0.10% of its reported portfolio and ranking #48.
Has SUSQUEHANNA ADVISORS GROUP, INC. been buying or selling ADPT?
In the latest 13F filing (Q2 2026), SUSQUEHANNA ADVISORS GROUP, INC. newly opened its position in ADPT.
Which other funds hold ADPT?
Other major institutional holders of ADPT include Viking Global Investors, VIKING GLOBAL INVESTORS LP, Aristotle Atlantic Partners, LLC, among 53 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.